AFTER THE appearance of preliminary reports of favorable effects of aureomycin, chloramphenicol, and oxytetracycline ("terramycin") in mumps, these three broad-spectrum antibiotics were studied systematically for symptomatic effects when given early in the course of mumps orchitis. A clear demonstration of therapeutic results was considered desirable because epidemic parotitis was the most frequent infection of known viral etiology in a medical service for adults and was. often associated with distressing symptoms. Mumps orchitis was found to present a course severe enough and consistent enough to allow conclusions to be drawn from a few cases in which the symptoms persisted despite therapy. LITERATURE Aureomycin.\p=m-\Tentativereports of favorable results of aureomycin therapy in mumps were made by four groups of investigators. Langley and Bryfogle 1 treated three patients with parotitis on the first, third, and seventh days of illness with symptomatic improvement four, five, and two days, respectively, after treatment was begun. Schmuttermeier, Swoboda, and Thalhammer2 treated one patient with parotitis and bilateral orchitis with aureomycin on the seventh day of disease. The treatment was begun four days after the onset of left orchitis and on the day of onset of right orchitis. Both swellings disappeared in two more days. Spinelli, Cressy, and Kunkel3 treated four patients with mumps orchitis on the second, first, fourth and seventh days, respectively, with disappearance of fever and symp¬ toms in 32 to 36 hours after therapy in all. Testicular swelling disappeared within three days. Schaub 4 reported 11 cases of parotitis in adults treated with aureomycin, Dr. Barnes is now at the United States Naval Hospital, Jacksonville, Fla.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.